Neuphoria Therapeutics NEUP
NASDAQ NEUP
$3.95 +0.00 (+0.00%)
As of: Aug 21, 2026 · 1:17 PM EDT

Neuphoria Therapeutics (NEUP) Operating Margin (2024 - 2025)

Neuphoria Therapeutics (NEUP) posted quarterly Operating Margin of 43981.65% for Q2 2025, up 54981.75% quarter-over-quarter from 79.85% in Q1 2025.

Neuphoria Therapeutics (NEUP) Operating Margin (2024 - 2025) Analysis & Trends

Neuphoria Therapeutics (NEUP) has reported Operating Margin for 2 consecutive years, with 43981.65% the latest figure, recorded in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Vertex Pharmaceuticals 138.90 Bn 131.05 Bn 2.84 Bn 37.40%
2 Regeneron Pharmaceuticals 86.10 Bn 78.11 Bn 3.93 Bn 30.15%
3 Argenx Se 65.56 Bn 60.37 Bn 1.37 Bn 32.54%
4 Moderna 55.82 Bn 50.68 Bn 52.00 Mn -562.07%
5 BeOne Medicines 42.14 Bn 37.04 Bn 1.53 Bn 19.06%
6 Alnylam Pharmaceuticals 31.67 Bn 28.36 Bn 992.69 Mn 17.93%
7 BioNTech SE 27.74 Bn 9.35 Bn 668.28 Mn -35.57%
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn -0.36%
9 Royalty Pharma 27.38 Bn 26.54 Bn - 19.75%
10 Neuphoria Therapeutics 21.37 Mn 1.93 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 43,981.65%
Mar 31, 2025 79.85%
Dec 31, 2024 -558.84%